Medicare Supplement Leads vs Advantage Leads: Two Different Businesses

Put a Medicare Supplement lead and a Medicare Advantage lead side by side in a CRM and you cannot tell them apart. Same age band, same ZIP, same phone, same consent language, often the same campaign. The difference only shows up later, when one converts in February and renews for nine years, and the other had to convert before 7 December or it was worth nothing.

The short answer: Medicare Advantage leads are a seasonal, volume, CMS-governed business with a hard commission ceiling. Medicare Supplement leads are a year-round, underwritten, state-regulated business where the money compounds on renewals. They are not two flavours of one vertical. They are two businesses that happen to talk to the same 66-year-old.

This is a commercial overview, not insurance or legal advice. Compensation limits, enrolment rules and state guaranteed-issue rights change annually. Verify current figures with CMS and with the Department of Insurance in each state you operate in before you build a model on them.

What is the difference between Medicare Supplement leads and Medicare Advantage leads?

A Medicare Advantage lead is a consumer request for help choosing a Part C plan, which replaces Original Medicare with a private plan bundling Part A, Part B and usually Part D, sold under CMS marketing rules with federally defined enrolment windows and federally capped broker compensation.

A Medicare Supplement lead is a consumer request for a quote on a Medigap policy, which sits alongside Original Medicare and pays the deductibles, coinsurance and copays Original Medicare leaves behind, sold by state-licensed carriers under state insurance law, medically underwritten outside protected windows, with no federal cap on what the carrier may pay.

Note what is on neither list: TCPA. Consent obligations apply identically to both, because they follow the phone call rather than the product. The consent standards lead buyers expect in 2026 and proof artefacts like TrustedForm and Jornaya certificates are table stakes on both sides.

Underwriting changes what a qualified Medigap lead even is

Medicare Advantage has no medical underwriting. If the person is eligible, lives in the plan's service area and is inside a valid enrolment window, they can enrol. Health status does not affect whether the sale happens, so an MA form capturing name, ZIP, date of birth, current coverage and consent has captured everything that determines whether the lead can close.

Medigap does not work that way. There is a federally protected Medigap open enrolment period: six months beginning the first month a person is both 65 or older and enrolled in Part B. Inside it, carriers must issue and cannot price on health. Outside it, and outside the specific guaranteed-issue situations set by federal law and by each state, the carrier may ask health questions and decline the application.

So a Medigap landing page carries a longer form than an MA landing page, and that is correct rather than a conversion failure. You are not underwriting. You are pre-screening so the agent is not paying full price for an application that will be rejected.

• Ask where they are in the Part B timeline. Whether the person is inside the six-month Medigap open enrolment window is the most predictive field on the form, because it decides whether health answers matter at all.
• Ask about current coverage. Someone already on a Medicare Advantage plan who wants Medigap is a harder and often time-locked case than someone on Original Medicare with no supplement.
• Ask tobacco status. It moves rated premium at most carriers and it costs you one field.
• Ask the named decline drivers. A short, plainly worded health block filters applications that will not be issued. Keep the wording neutral and never imply a decision.
• Record state, not just ZIP. Medigap rules, guaranteed-issue rights and switching windows are set state by state, so state is a routing key rather than a nicety.

There is a pricing consequence. Because Medigap leads can be pre-screened on health and MA leads cannot, a Medigap lead is far more differentiable. In MA, every generator captures roughly the same seven fields, so the product commoditises and AEP bidding becomes a pure volume auction, which is what drives the seasonal cost curve in Medicare lead pricing. In Medigap you can build a genuinely better lead, and buyers will pay the difference.

Guaranteed-issue windows create the demand spikes Medigap does have

Medigap is year-round but not flat. Demand clusters around the moments a person can get a policy without answering health questions, and those moments are defined by rule rather than by marketing.

Medigap demand spikes are triggered by individual life events spread across the calendar. Medicare Advantage demand is triggered by one national date range that hits everybody at once. Event-driven demand can be met with evergreen organic content and steady spend. Calendar-driven demand cannot, which is the whole problem in our companion piece on planning Medicare Advantage lead supply for AEP 2027.

Why year-round sellability reshapes the whole business

An MA lead business has to earn most of its year inside 54 days. You carry fixed costs for ten months against thin revenue, compete for media in the most expensive eight weeks of the insurance year, and hire agents you cannot keep busy in May. Every mistake made in October is unrecoverable, because there is no second attempt until next October.

A Medigap lead business bills every month. The same SEO asset earns in March as in November, media can be tested at low volume and scaled on measured return, and agent capacity stays utilised.

If you are choosing where to put an SEO investment, that last row is the argument. Medigap explainers about the six-month window, a state's birthday rule, or what happens to a supplement when someone moves states keep earning for years. MA plan-comparison content has a shelf life of one plan year.

Persistency is what a Medigap lead buyer is actually paying for

Medigap commission is typically a percentage of the policy premium, paid at a higher rate in the first year and a lower rate on renewal for a defined number of years. Because it is a share of an ongoing premium, the agent's economics depend on how long the policy stays on the books. A policy that lapses at month 11 can be worse than no sale, because some carriers charge back first-year commission on early lapse.

Medicare Advantage compensation is a capped flat amount instead. CMS sets national initial and renewal limits, publishes them each year, and sets higher amounts for a small number of states, so the upside per enrolment is bounded no matter how good the client is. Our piece on how money moves through Medicare affiliate programmes traces that ceiling down to publisher payouts. Do not quote a rate from memory. The CMS annual compensation notice is the authority and it moves.

So a Medigap buyer is buying a stream and an MA buyer is buying an event. Stream buyers care about what predicts longevity. Rating method matters, because an attained-age policy whose premium climbs every year produces a client who shops again in three years, while community-rated and issue-age policies are stickier. Intent quality matters, because someone who searched for what Medigap covers behaves nothing like someone who clicked a gift card offer.

Why the two should not share a landing page or a buyer panel

One Medicare landing page, one form, route by whatever the person ticks. It is cheaper to build and it feels like sensible consolidation. It fails on four axes.

The forms differ. An MA form with five added health questions loses conversion for nothing, because health is irrelevant to MA enrolment. A Medigap form without them produces leads that get declined. You cannot optimise one form for both without degrading one.

The compliance surfaces differ. Generate MA or Part D leads and you are almost certainly a Third Party Marketing Organisation under CMS rules, with disclaimer requirements, call-recording obligations and duties flowing back to plans. Those CMS rules do not govern Medigap-only marketing. Mixing both on one page means either applying TPMO requirements to traffic that does not need them, or running MA traffic through a page missing the required disclaimer. Our overview of TPMO compliance in Medicare lead generation covers where that line sits, and CMS is the authority on current wording.

The seasonality differs. A shared page means shared campaign history and shared learning data. Your Medigap performance gets buried inside an October spike that has nothing to do with it, and February looks like a collapse because the AEP traffic left.

The buyers will damage each other's pricing. In one panel, MA buyers see Medigap leads they cannot use and Medigap buyers see unscreened MA leads, and both discount your feed for mix risk. On ping-post this is immediate: mismatched leads get pinged to buyers who reject them, accept rate drops, and your position in the waterfall degrades. The mechanics are in our explainer on how ping-post lead distribution works.

Run two properties. Two forms, two buyer panels, two reporting lines. Share the data layer and the consent infrastructure, not the funnel.

Which vertical should an operator build?

Position first: if you are starting from zero with limited capital and no existing Medicare buyer relationships, build Medigap.

The reasoning is survivability, not upside. An MA business demands you be good at a compressed, expensive, federally regulated auction on your first attempt, and gives you one shot a year to learn. A first AEP that goes badly costs you twelve months. Medigap lets you test in March, be wrong, fix it in April and test again, which is how anyone actually learns a vertical. It also lets organic content compound, because the material does not expire annually.

Build Medicare Advantage first only if one of these is true: you already have committed buyers who have told you what they will pay and how much they will take, you have capital to absorb a losing AEP, or you run an existing high-volume media operation where the seasonal spike is incremental use of infrastructure you already have.

One more path is worth naming. The turning-65 audience sits upstream of both decisions, before the person has chosen MA or Medigap at all, and both sets of buyers want them. That is a different acquisition motion, covered in how T65 Medicare leads work for people turning 65. Whichever you pick, the build discipline is the same as any regulated vertical: documented consent, source-level attribution, honest disclosure, and the ability to prove where every record came from, which is the standard in our publisher vetting checklist for insurance.

Common questions

Can the same lead be sold as both a Medicare Supplement and a Medicare Advantage lead? The contact record is the same person, but selling it as both is a bad idea. The buyers want different qualification data, the compliance requirements differ, and the consumer ends up taking calls pitching opposing products. If the person is genuinely open to both, disclose that and price it as an undecided lead rather than double-representing it.

Does a Medigap lead need TCPA consent the same way a Medicare Advantage lead does? Yes. TCPA follows the outbound call or text, not the insurance product, so consent standards, revocation handling and proof of consent apply identically. What differs is the layer on top: MA and Part D marketing carries additional CMS disclaimer and recording requirements that Medigap-only marketing does not. Treat TCPA as the floor for both.

Why do Medicare Supplement lead prices vary so much between sources? Because the leads genuinely are different products. A Medigap lead screened for health, tobacco and Part B enrolment date converts to an issued-and-paid policy at a materially different rate than an unscreened one, and buyers who measure persistency know it. Unlike Medicare Advantage, where qualification data is near identical across vendors, Medigap quality is buildable and therefore priceable.

Is Medicare Supplement commission capped by CMS like Medicare Advantage commission is? No. CMS caps broker compensation for Medicare Advantage and Part D and publishes the limits annually. Medigap is a state-regulated private product, so commission is set by the carrier as a percentage of premium under state law, with its own first-year and renewal structure. Never quote either figure from memory. Check the current CMS notice and the carrier schedule.

What is the birthday rule and why does it matter for Medigap lead generation? A birthday rule is a state provision letting an existing Medigap policyholder switch to a plan with equal or lesser benefits within a defined window around their birthday without medical underwriting. In states that have one it creates predictable, dateable switching demand you can build campaigns around. The list of states changes, so verify with each state Department of Insurance.

Should a small agency run both Medicare Supplement and Medicare Advantage lead campaigns at once? Not in year one. Running both means maintaining two forms, two compliance postures, two buyer panels and two seasonal plans with a team that has not yet proven it can run one. Build the year-round Medigap operation until it is stable and profitable, then add Medicare Advantage as a separate seasonal property ahead of the next AEP.